Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
FASEB Bioadvances|March 4, 2020
High-level expression of STING restricts susceptibility to HBV by mediating type III IFN inductionHiromichi Dansako, Hirotaka Imai, Youki Ueda, et al.
Acta Medica Okayama|April 21, 2016
Rab13 Is Involved in the Entry Step of Hepatitis C Virus InfectionMidori Takeda, Masanori Ikeda, Shinya Satoh, et al.
Archives of Virology|September 26, 2009
HCV genotype 1b chimeric replicon with NS5B of JFH-1 exhibited resistance to cyclosporine AKen-ichi Abe, Masanori Ikeda, Yasuo Ariumi, et al.
Virus Research|November 30, 2004
cDNA microarray analysis to compare HCV subgenomic replicon cells with their cured cellsKen-ichi Abe, Masanori Ikeda, Hiromichi Dansako, et al.
Hepatology (Baltimore, Md.)|June 27, 2006
Different anti-HCV profiles of statins and their potential for combination therapy with interferonMasanori Ikeda, Ken-ichi Abe, Masashi Yamada, et al.
Biochemical and Biophysical Research Communications|March 16, 2005
Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter systemMasanori Ikeda, Ken-Ichi Abe, Hiromichi Dansako, et al.
Biochemical and Biophysical Research Communications|April 15, 2008
New efficient replication system with hepatitis C virus genome derived from a patient with acute hepatitis CKyoko Mori, Ken-Ichi Abe, Hiromichi Dansako, et al.
Pageof 8